1 / 5

2017 Rheumatoid Arthritis-API Market Insights

India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.<br><br>Complete report available at: http://www.marketreportsonline.com/566856.html<br>

tim54
Download Presentation

2017 Rheumatoid Arthritis-API Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rheumatoid Arthritis-API Insights, 2017 Order this report by calling +1 888 391 5441 or Send an email to sales@marketreportsonline.com with your contact details and questions if any. • Published: January 2017 • Pages: 60 • Price: US$ 1250 (Single User License)

  2. Rheumatoid Arthritis-API Insights, 2017 • The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. • India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China. • Rheumatoid Arthritis -API Insights, 2017 Report describes the current therapeutics that is propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Rheumatoid Arthritis. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent and patent exclusivity information. The research analysis also presents the global sales data till 2016. Data Sources

  3. Rheumatoid Arthritis-API Insights, 2017 • Scope: • A snapshot of the global Market therapeutics scenario for Rheumatoid Arthritis. • A review of the marketed products under prescription for Rheumatoid Arthritis, regulatory information and marketing status. • Coverage of global patent coverage and detailed commentaries on the US patent challenges. • Graphical representation of investigational products for patent expiry and market exclusivities across the globe. • Product profiles for marketed products for Rheumatoid Arthritis with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details. • Coverage of API Manufacturers for Rheumatoid Arthritis drugs in the United States, Europe and Asian Regions with location details. • Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Rheumatoid Arthritis drugs. • Key discontinued Marketed products. • Global Sales Figure from 2012-2016.Reasons to Buy • Evaluate the marketing status and exclusivity details of Rheumatoid Arthritis key products to exploit opportunities for generic drug development opportunities. • Key players in the pharmaceutical industry. • Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified. • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Rheumatoid Arthritis. • API intelligence over marketed drugs for Rheumatoid Arthritis and gaining primary intelligence over active ingredients manufacturers across the globe.

  4. Rheumatoid Arthritis-API Insights, 2017 • Major Points from Table of Contents: • Rheumatoid Arthritis Therapeutic Market, US, Marketed Drugs by Application Type, 2017 • Rheumatoid Arthritis Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017 • Rheumatoid Arthritis Therapeutic Market, US, (Year), 2017 • Rheumatoid Arthritis Marketed Drugs, API Manufacturers by US DMF Status, 2017 • Rheumatoid Arthritis Marketed Drugs, US DMF Status Drug Specific (Number), 2017 • Rheumatoid Arthritis Therapeutic Market, Global Sales (in million USD), 2017 • Rheumatoid Arthritis Marketed Drugs, API Manufacturers, Global, 2017 • Discontinued Drugs for Rheumatoid Arthritis, 2017 • For Fax Order Request Form Click Here • Buy Report @ http://www.marketreportsonline.com/contacts/purchase.php?name=566856

  5. Rheumatoid Arthritis-API Insights, 2017 About Us: MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports. Contact Us: RiteshTiwari 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune, Maharashtra, India Tel: + 1 888 391 5441 E-mail: sales@marketreportsonline.com http://www.marketreportsonline.com/

More Related